Clinical Trials on Dyslipidemias in Poland
Total 183 results
-
GlaxoSmithKlineCompletedDyslipidaemiasUnited States, Canada
-
AstraZenecaCompletedDyslipidaemiaRussian Federation
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
Medical University of SilesiaUnknownInflammation | Diabetes | Dyslipidemia | CytokinesPoland
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Erasmus Medical CenterDutch Heart FoundationCompletedDecision Support Systems, ClinicalNetherlands
-
AbbottCompletedHyperlipidemia | Mixed DyslipidemiaUnited States
-
Poznan University of Physical EducationPoznan University of Medical SciencesCompletedHypertension | Obesity | Dyslipidemias | Type 2 Diabetes | Endothelial DysfunctionPoland
-
Kowa Research Institute, Inc.CompletedMixed Dyslipidemia | Primary DyslipidemiaUnited States
-
Daiichi SankyoDaiichi Sankyo Korea Co., Ltd.Active, not recruiting
-
AmgenCompletedDyslipidemiaUnited States, Poland, Czechia, Hungary, Russian Federation, Ukraine, Slovakia
-
Arrowhead PharmaceuticalsActive, not recruitingDyslipidemiasUnited States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
-
Bristol-Myers SquibbCompletedDyslipidemiaUnited States, Canada
-
AbbottCompletedDyslipidemiaArgentina, Czech Republic, Germany, Mexico, Poland, Romania, Russian Federation
-
Zydus Therapeutics Inc.Suspended
-
Medical University of BialystokUniversity of CopenhagenRecruitingObesity | Diabetes Mellitus | Metabolic Syndrome | Dyslipidemias | PreDiabetesPoland
-
TakedaCompletedHypercholesterolemiaPoland, United Kingdom, Germany, South Africa, Finland, Estonia, Czech Republic
-
TakedaCompletedDyslipidemiaUnited States, Germany, Argentina, Mexico, Poland, South Africa, Chile, Netherlands, Peru, Estonia, Russian Federation, Czech Republic, Hungary, Lithuania, Latvia, Slovakia, United Kingdom
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
AmgenCompletedDyslipidemiaUnited States, Belgium, Denmark, Finland, France, Italy, Spain, Hungary, Poland, Germany, Czechia, Turkey, United Kingdom, Malaysia, Australia, Hong Kong, New Zealand, Canada, South Africa, Greece, Portugal, Netherlands, Russian Federation and more
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderCzech Republic, France, Hungary, India, Lithuania, Poland, Slovakia
-
TakedaCompletedDyslipidemiaUnited States
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
Eli Lilly and CompanyCompleted
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
PfizerCompletedHyperlipidemiaFinland, Netherlands, United States, Canada, Sweden, Korea, Republic of, Singapore, Czechia, Poland, United Kingdom, Puerto Rico, Norway
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
Medical University of BialystokUniversity of CopenhagenEnrolling by invitationObesity | Overweight | Dyslipidemias | PreDiabetes | Type 2 DiabetesPoland
-
Kowa Research Institute, Inc.WithdrawnDyslipidemia | HyperlipidemiaUnited States
-
Eli Lilly and CompanyActive, not recruitingMetabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | HyperlipoproteinemiaUnited States, Mexico, Poland, Canada, Turkey, Japan, Argentina
-
AmgenCompletedDyslipidemiaUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Czechia, Hungary, Taiwan, Colombia, Poland, Russian Federation, Switzerland, Korea, Republic of, Mexico, ... and more
-
Poznan University of Medical SciencesUnknownGlucose Metabolism Disorders | Hypertension | Obesity | Nutrition Disorders | Metabolic Syndrome | Dyslipidemias | Glucose Intolerance | Overweight and ObesityPoland
-
PfizerCompletedHyperlipidemiaUnited States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
-
Kowa Research EuropeCompletedDyslipidemia | HypercholesterolemiaSpain, Denmark, India, Israel, Sweden, Finland, Germany, Italy, Netherlands, Norway, Poland, Russian Federation, United Kingdom
-
Eli Lilly and CompanyCompletedDyslipidemiaUnited States, Netherlands, Germany, Denmark, Poland, United Kingdom
-
PfizerTIMI Study GroupCompletedDyslipidemias | Hyperlipidemias | HyperlipoproteinemiasUnited States, Canada, Poland
-
PfizerTerminatedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
Providence VA Medical CenterSandra A. Daugherty FoundationCompletedHypertension | Diabetes | DyslipidemiaUnited States
-
PfizerCompletedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
PfizerTerminatedDyslipidemia | HyperlipidemiaUnited States
-
Kowa Research EuropeCompletedDyslipidemia | Primary HypercholesterolemiaSpain, Denmark, India, Israel, Sweden, Finland, Germany, Italy, Netherlands, Norway, Poland, Russian Federation, United Kingdom
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | DyslipidemiaUnited States
-
AmgenCompletedDyslipidemia | Medical Conditions to be Studied | ASCVD ManagementUnited States
-
AbbottCompleted
-
Medical University of WarsawCompletedHypertension | Diabetes Mellitus | Dyslipidemia | Morbid Obesity | Metabolic Syndrome XPoland
-
AmgenCompletedType 2 Diabetes | Hypercholesterolemia | Mixed DyslipidemiaUnited States, Italy, Belgium, Spain, Canada, Poland, Mexico
-
AbbottCompletedDyslipidemiaUnited States